🇨🇭 Roivant Sciences Ltd.
Forum topic · ROIV · Company page: financials, ownership and filings
Join the discussion on Roivant Sciences Ltd.
Loading…
Results announced on 9 November 2026
Roivant Sciences Ltd. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $35 million (up 2137% from a year earlier) and a net loss of $192 million.
Insider trading in October 2026
Directors and officers of Roivant Sciences Ltd. reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $14,981,529 in 5 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 361 funds hold $6.5 billion
361 mutual funds in 3 countries hold shares of Roivant Sciences Ltd. worth $6.5 billion, about 26.6% of the company (funds' newest reports, up to 31 October 2026).
Since their previous reports 213 funds added shares and 106 sold; on balance they bought $79 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.